Related Experiment Video

Updated: Jul 29, 2026

Isolation and Physiological Analysis of Mouse Cardiomyocytes
11:02

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Published on: September 7, 2014

[Cardiomyocyte cytoskeleton in dilated cardiomyopathy and ischemic heart disease]

L V Beletskaia, L B Zhbanova, V A Zaĭdenov

    Arkhiv Patologii
    |March 1, 1996
    PubMed

    Insights

    Vinculin protein in heart muscle cells is disorganized and increased in dilated cardiomyopathy, potentially reducing heart function. Ischemic heart disease also shows higher vinculin, but to a lesser extent.

    Area of Science:

    • Cardiovascular Biology
    • Cellular Biology
    • Protein Biochemistry

    Context:

    • Investigating the structural and molecular changes in cardiomyocytes.
    • Focusing on cytoskeletal proteins in myocardial diseases.
    • Utilizing immunofluorescence and monoclonal antibodies for protein detection.

    Purpose:

    • To quantify and localize vinculin in the cardiomyocyte cytoskeleton.
    • To compare vinculin levels in normal hearts versus those with dilated cardiomyopathy (DCM) and ischemic heart disease (IHD).
    • To assess the potential impact of altered vinculin on cardiomyocyte function.

    Summary:

    • Vinculin, a key cytoskeletal protein, was identified in the myocardium of patients with DCM and IHD.
    • Cardiomyocytes in DCM exhibited a disorganized, hypertrophic cytoskeleton with significantly elevated vinculin levels compared to normal controls.
    • Patients with IHD also showed increased vinculin, though less pronounced than in DCM, suggesting a role in myocardial dysfunction.

    Impact:

    • Findings suggest that increased vinculin in DCM may impair cardiomyocyte contractility.
    • Highlights potential molecular mechanisms underlying heart failure in DCM and IHD.
    • Provides insights into cytoskeletal remodeling in response to cardiac pathology.

    More Related Videos

    Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

    Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

    Published on: June 14, 2016

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

    Published on: May 16, 2020

    Related Concept Videos

    Structure of Cardiac Muscles01:13

    Structure of Cardiac Muscles

    Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
    Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
    Myocarditis I: Introduction01:21

    Myocarditis I: Introduction

    Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...